A Study of Probiotics in Patients With Acute Ischemic Stroke

Sex: All

Ages: 60 Years – N/A

Healthy volunteers: No

Phase: PHASE2

Enrollment: 220

Sponsor: Capital Medical University

Summary

The primary objective of this study is to evaluate the effect of daily oral administration of the probiotic supplement OMNi-BiOTiC® SR-9 for 90 days, compared to placebo, on gut microbiome beta diversity in patients aged 60 years or older with acute ischemic stroke.

Eligibility Criteria

Inclusion Criteria: 1. Age ≥ 60 years; 2. Diagnosis of ischemic stroke; (1)Ischemic stroke is defined as clinically manifest acute neurological deficits linked to an acute cerebral infarct in the anterior circulation; (2)Central retinal artery occlusion or likely central retinal artery occlusion are not considered ischemic strokes in the context of this trial; 3. Randomization within 72 hours of symptom onset; 4. Ability to provide written informed consent; 5. Baseline NIHSS \>=4; 6. Pre-stroke mRS \

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07651332). StuddyBuddy aggregates publicly available trial information.